Skip to content
Canli Capital

Research

Weighting x Breadth Construction Grid (campaign): a killed candidate

Verdict: KILLED Stage: screen prototype
Identity: alphamax_weightgrid

Four weightings (inverse-vol, equal, signal-proportional, vol-capped) crossed with four breadths (K=30/50/100/200), 2005-2026, live cell inverse-vol K=100. Net Sharpes span -0.293 to +0.066 against the live cell's -0.062 on the same harness (this is the deep-history panel, where the deployed 2023+ sleeve's 0.91 does not apply). Four of the 15 challenger cells individually cleared the 90% paired bootstrap — but the bootstrap's own dSharpe intervals imply those cells are 0.97 to 1.00 correlated with the live cell, so four passes is about the chance expectation for a family of near-copies, not evidence. The family-wise White Reality Check over the whole grid returns p=0.315: the best cell (signal-proportional K=50, dSharpe +0.128) is indistinguishable from luck. That family-wise gate was pre-registered precisely so the best cell could not be harvested. Zero cells adoptable; keep inverse-vol K=100. 0 trial slots burned. Reproduce: scripts/probe_alphamax_weighting.py.

Why it was worth testing

This died at the screen stage, before a full walk-forward was ever run. Screening exists so that ideas which cannot clear a coarse, cost-aware bar do not consume the far more expensive machinery behind it. A screen kill is a cheap kill, and it is published for the same reason as an expensive one: the trial was still spent, and it still raises the evidence bar for everything already in the book.

The result

Measure Value
Screen net Sharpe 0.0660

What this does and does not say

It says this configuration, on this data, net of the costs we charge, did not clear the bar it pre-registered. It does not say the underlying economic effect does not exist, that no implementation of it works, or that someone with different data or different execution would reach the same conclusion. A null is evidence about a test, not a proof about a market.

It also does not say the trial was free. Every hypothesis tested raises the deflated-Sharpe hurdle for every sleeve already in the book, including the ones that survived. That is why the kill count is published beside the survivor count rather than behind it.